Literature DB >> 4092890

Treatment of poisoning by soman.

L Leadbeater, R H Inns, J M Rylands.   

Abstract

The efficacies of a number of drug treatment combinations in protecting guinea pigs against the lethal and incapacitating effects of soman (and sarin) have been determined. Incapacitation was studied using a swimming test which is a measure of gross motor performance. The drug combinations employed had no effect on the swimming performance of unpoisoned animals. Pyridostigmine pretreatment supported by postpoisoning therapy with atropine, pralidoxime mesylate (P2S), and diazepam protected guinea pigs against the lethal actions of soman and sarin, but the treatment was less effective in protecting against the agent-induced decrements in swimming performance. Replacing pyridostigmine (a quaternary carbamate) by physostigmine (which readily enters the CNS) and introducing aprophen (an anti-cholinergic drug with a range of pharmacological actions) improved the protection achieved against both lethality and incapacitation. When the postpoisoning therapy was omitted, pretreatment with physostigmine and aprophen (or some other anti-cholinergic drug) gave significant levels of protection against both soman- and sarin-induced lethality and incapacitation. It is concluded that a number of different pharmacological actions are required to antagonize nerve agent-induced incapacitation and that they, and their relative importance, remain to be identified.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4092890     DOI: 10.1016/0272-0590(85)90132-0

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  11 in total

1.  Protection of guinea pigs against soman poisoning with ferrocene carbamate.

Authors:  N Karlsson; R Larsson; G Puu
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

2.  Effects of organophosphorus anticholinesterases on nicotinic receptor ion channels at adult mouse muscle endplates.

Authors:  J E Tattersall
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

3.  Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.

Authors:  Edson X Albuquerque; Edna F R Pereira; Yasco Aracava; William P Fawcett; Maristela Oliveira; William R Randall; Tracey A Hamilton; Robert K Kan; James A Romano; Michael Adler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-16       Impact factor: 11.205

Review 4.  Cholinesterases and the fine line between poison and remedy.

Authors:  Carey N Pope; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2018-01-31       Impact factor: 5.858

5.  Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus).

Authors:  N G Muggleton; A P Bowditch; H S Crofts; E A M Scott; P C Pearce
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

6.  Prevention of physostigmine-, DFP-, and diazinon-induced acute toxicity by monoethylcholine and N-aminodeanol.

Authors:  T A Patterson; A V Terry; J W Kosh
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

7.  A rodent model of human organophosphate exposure producing status epilepticus and neuropathology.

Authors:  W Pouliot; S L Bealer; B Roach; F E Dudek
Journal:  Neurotoxicology       Date:  2016-08-12       Impact factor: 4.294

8.  Effect of pyridostigmine pretreatment, HI-6 and Toxogonin treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure.

Authors:  P Walday; P Aas; T Haider; F Fonnum
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

9.  Protection against the effects of anticholinesterases on the latencies of action potentials in mouse skeletal muscles.

Authors:  S S Kelly; C B Ferry; J P Bamforth; S K Das
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

10.  Antiseizure and neuroprotective effects of delayed treatment with midazolam in a rodent model of organophosphate exposure.

Authors:  Jay Spampanato; Wendy Pouliot; Steven L Bealer; Bonnie Roach; Francis Edward Dudek
Journal:  Epilepsia       Date:  2019-05-24       Impact factor: 6.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.